OA13.06 Surgical Outcomes Following Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Non-Small Cell Lung Cancer - NEOSTAR Study

MLA

David C. Rice, et al. “OA13.06 Surgical Outcomes Following Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Non-Small Cell Lung Cancer - NEOSTAR Study.” Journal of Thoracic Oncology, vol. 14, Oct. 2019, pp. S241–42. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........a941baff3b99a537896287ed56453e9b&authtype=sso&custid=ns315887.

APA

David C. Rice, H. Lin, Wayne L. Hofstetter, John V. Heymach, Anne Tsao, Tina Cascone, Annikka Weissferdt, Jack A. Roth, S.G. Swisher, Charles Lu, A. Vaporciyan, Bonnie S. Glisson, Mara B. Antonoff, Lauren Averett Byers, Vincent K. Lam, Vassiliki A. Papadimitrakopoulou, Jangsoon Lee, Yasir Elamin, Frank V. Fossella, … Cheuk Hong Leung. (2019). OA13.06 Surgical Outcomes Following Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Non-Small Cell Lung Cancer - NEOSTAR Study. Journal of Thoracic Oncology, 14, S241–S242.

Chicago

David C. Rice, H. Lin, Wayne L. Hofstetter, John V. Heymach, Anne Tsao, Tina Cascone, Annikka Weissferdt, et al. 2019. “OA13.06 Surgical Outcomes Following Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Non-Small Cell Lung Cancer - NEOSTAR Study.” Journal of Thoracic Oncology 14 (October): S241–42. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........a941baff3b99a537896287ed56453e9b&authtype=sso&custid=ns315887.